Results 31 to 40 of about 1,649,429 (264)
Clinical Characteristics and Survival Outcomes of Patients with De Novo Metastatic Breast Cancer
Breast Cancer: Targets and Therapy, 2022 Hanan Almasri,1 Ayah Erjan,1 Hebah Abudawaba,1 Khaled Ashouri,2 Sara Mheid,1 Anoud Alnsour,1 Hikmat Abdel-Razeq2,3 1Department of Radiation Oncology, King Hussein Cancer Center, Amman, Jordan; 2Department of Internal Medicine, King Hussein Cancer Center,
Almasri H +6 more
doaj
Cancer Medicine, 2020 Background Patients with early‐stage breast cancer (BC) live long but have competing comorbidities. This study aimed to estimate the effect of cancer and other causes of death in patients with early‐stage BC and further quantify the survival differences.
Yan‐Bo Xu +5 more
doaj +1 more source
Prediction of Overall Survival of Brain Tumor Patients [PDF]
TENCON 2019 - 2019 IEEE Region 10 Conference (TENCON), 2019 Automated brain tumor segmentation plays an important role in the diagnosis and prognosis of the patient. In addition, features from the tumorous brain help in predicting patients overall survival. The main focus of this paper is to segment tumor from BRATS 2018 benchmark dataset and use age, shape and volumetric features to predict overall survival of
Rupal R. Agravat, Mehul S. Raval
openaire +2 more sources
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background Survival after relapse in pediatric acute myeloid leukemia (AML) remains poor, highlighting the critical importance of identifying prognostic factors to guide optimal relapse management. Methods We investigated the prognostic impact of multiparameter flow cytometry (MFC) measurable residual disease (MRD) in 188 patients with first ...
Camilla Poulsen +21 more
wiley +1 more source
Childhood Hodgkin Lymphoma in Iran; survival and outcome
Pediatric Hematology Oncology Journal, 2020 Background: Staging has an important role in both defining the prognosis of Hodgkin lymphoma (HL) and choosing the best treatment protocol. This study was designed to evaluate the features of HL and estimate the survival rate in patients referred to ...
Azim Mehrvar +7 more
doaj +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT Purpose Despite 5‐year survival rates of over 90% among children and adolescents/young adults (CAYAs) with classic Hodgkin lymphoma (cHL), 15%–20% relapse after frontline therapy. Prior analysis of frontline Children's Oncology Group (COG) clinical trials demonstrated that, despite similar rates of relapse, non‐Hispanic Black (NHB) and ...
Mallorie B. Heneghan +14 more
wiley +1 more source
Cancer Management and Research, 2019 Kexin Ma,* Bing Dong,* Liming Wang, Chongyu Zhao, Zhaoyu Fu, Chi Che, Wuguang Liu, Zexuan Yang, Rui LiangDepartment of Hepatobiliary Surgery, The Second Hospital of Dalian Medical University, Dalian, Liaoning, People’s Republic of China*These ...
Ma K +8 more
doaj
Prognostic and predictive value of radiomics signatures in stage I‐III colon cancer
Clinical and Translational Medicine, 2020 Accurate identification of patients with poor prognosis after radical surgery is essential for clinical management of colon cancer. Thus, we aimed to develop death and relapse specific radiomics signatures to individually estimate overall survival (OS ...
Weixing Dai +7 more
doaj +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT Introduction Anthracycline‐related cardiac remodeling precedes heart failure in childhood cancer survivors. The objectives of this study were to determine the relationships between patient‐specific factors, moderate‐to‐vigorous physical activity (MVPA), and cardiac remodeling.
Hari K. Narayan +15 more
wiley +1 more source
Cancer Management and Research, 2014 Yiyun Tang,1 Paul Bycott,1 Örjan Åkerborg,2 Linus Jönsson,2 Sylvie Negrier,3 Connie Chen4 1Pfizer Global Research and Development, La Jolla, CA, USA; 2OptumInsight, Stockholm, Sweden; 3Medical Oncology Department, University of Lyon, Lyon,
Tang Y +5 more
doaj